Shop

Author at Microdose

Microdose NewsDesk

Microdose's editorial department brings you the latest news and industry insights.

Law & Politics

23 Mar 2023

Psychedelic Medicine PAC (Political Action Committee) Launches in Washington

"A political action committee (PAC) is a political committee that pools campaign contributions from members and donates those funds to campaigns for or against candidates, ballot initiatives, or legislation....

By Microdose NewsDesk

Breaking News, Industry

22 Mar 2023

Field Trip Health & Wellness Files for Credit Protection; CEO Resigns

For more on Field Trip's recent news, see Field Trip Health & Wellness to Close Clinics in 5 Locations   Field Trip Health & Wellness Obtains CCAA Protection   TORONTO,...

By Microdose NewsDesk

Law & Politics

22 Mar 2023

Decrim Update: Psychedelic Bills Move Forward in Several States

2023 has started off as a good year for psychedelic decriminalization....

By Microdose NewsDesk

Science

21 Mar 2023

New Study Gives Most Advanced View of the Brain on Psychedelics

A new study looking at DMT effects on the brain has produced the most detailed view yet of psychedelics and DMT's powerful potential....

By Microdose NewsDesk

Join Our Newsletter for Exclusive Updates, Stories, and More

Don’t Miss

20 Mar 2023

News You Might Have Missed: March 20th, 2023

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed....

By Microdose NewsDesk

Industry

16 Mar 2023

Filament Health Announces FDA Approval Of Phase II Clinical Trial

Filament Health Announces FDA Approval Of Phase II Clinical Trial Studying Psilocybin For Methamphetamine Use Disorder...

By Microdose NewsDesk

Industry

15 Mar 2023

Field Trip Health & Wellness to Close Clinics in 5 Locations

In an effort to reduce expenditures, Field Trip Health will close clinics located in Chicago, Washington DC, Seattle, San Diego and Fredericton....

By Microdose NewsDesk

Don’t Miss

13 Mar 2023

News You Might Have Missed: March 13th, 2023

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed....

By Microdose NewsDesk

Science

10 Mar 2023

New Study: Challenging Psychedelic Trips Lead to Positive Mental Health

A new study suggests that challenging and mystical psychedelic experiences may be connected to improved mental health outcomes....

By Microdose NewsDesk

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

You Might Also Like

17 Dec 2025

Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward

If 2024 was the year the psychedelic field learned how hard “approval ready” really is, 2025 was the year it began behaving accordingly. The past twelve months were less about...

By Madison Roberts

26 Nov 2025

Delix Therapeutics Reports Strong Phase Ib Results

Delix Therapeutics recently announced compelling data from a Phase Ib trial of DLX-001 (zalsupindole), a non-hallucinogenic neuroplastogen. According to the company’s release, DLX-001 produced robust biomarker signals (quantitative EEG and...

By Madison Roberts

19 Nov 2025

Childhood Trauma’s Role in Men’s Substance Use Disorders

Childhood trauma leaves a deeper imprint on men’s lives than most realize—and for many, it becomes the hidden engine driving substance use disorders. Research shows that emotional abuse, physical violence,...

By Madison Roberts

19 Nov 2025

Human-Centered AI in Healthcare

Artificial intelligence is redefining modern healthcare, offering powerful tools that enhance diagnosis, expedite drug discovery, and enable truly personalized treatment. As health systems struggle with rising costs, aging populations, and...

By Madison Roberts

16 Oct 2025

Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up

As Big Pharma makes billion-dollar bets in the evolving landscape of neuropsychiatric therapeutics, Enveric Biosciences (NASDAQ: ENVB) is carving out a formidable position — not by chasing headlines, but by...

By Madison Roberts

15 Oct 2025

The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch

Take Enveric Biosciences (NASDAQ: ENVB), a company that’s been flying under the radar while building an IP fortress around a novel class of non-hallucinogenic neuroplastogens. Now, that fortress is being...

By Madison Roberts
WordPress Ads
No Result
View All Result

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.